436 related articles for article (PubMed ID: 20736231)
1. Sugammadex reversal of rocuronium-induced neuromuscular block in Caesarean section patients: a series of seven cases.
Pühringer FK; Kristen P; Rex C
Br J Anaesth; 2010 Nov; 105(5):657-60. PubMed ID: 20736231
[TBL] [Abstract][Full Text] [Related]
2. Reversal of rocuronium-induced neuromuscular block with sugammadex is faster than reversal of cisatracurium-induced block with neostigmine.
Flockton EA; Mastronardi P; Hunter JM; Gomar C; Mirakhur RK; Aguilera L; Giunta FG; Meistelman C; Prins ME
Br J Anaesth; 2008 May; 100(5):622-30. PubMed ID: 18385265
[TBL] [Abstract][Full Text] [Related]
3. [Use of sugammadex in patients undergoing caesarean section using general anesthesia with rocuronium].
Shibusawa M; Ejima Y; Nishino R; Toyama H; Kurosawa S
Masui; 2012 Aug; 61(8):805-9. PubMed ID: 22991799
[TBL] [Abstract][Full Text] [Related]
4. Multicentre, parallel-group, comparative trial evaluating the efficacy and safety of sugammadex in patients with end-stage renal failure or normal renal function.
Staals LM; Snoeck MM; Driessen JJ; Flockton EA; Heeringa M; Hunter JM
Br J Anaesth; 2008 Oct; 101(4):492-7. PubMed ID: 18653492
[TBL] [Abstract][Full Text] [Related]
5. Sugammadex rapidly reverses moderate rocuronium- or vecuronium-induced neuromuscular block during sevoflurane anaesthesia: a dose-response relationship.
Pühringer FK; Gordon M; Demeyer I; Sparr HJ; Ingimarsson J; Klarin B; van Duijnhoven W; Heeringa M
Br J Anaesth; 2010 Nov; 105(5):610-9. PubMed ID: 20876699
[TBL] [Abstract][Full Text] [Related]
6. Org 25969 (sugammadex), a selective relaxant binding agent for antagonism of prolonged rocuronium-induced neuromuscular block.
Shields M; Giovannelli M; Mirakhur RK; Moppett I; Adams J; Hermens Y
Br J Anaesth; 2006 Jan; 96(1):36-43. PubMed ID: 16357116
[TBL] [Abstract][Full Text] [Related]
7. [Reversal of rocuronium-induced neuromuscular blockade with sugammadex in patients for cesarean delivery treated with magnesium sulfate].
Sakurai Y; Uchida M; Aiba J; Mimura F; Yamaguchi M; Kakumoto M
Masui; 2014 Mar; 63(3):315-9. PubMed ID: 24724442
[TBL] [Abstract][Full Text] [Related]
8. Time course of action of sugammadex (Org 25969) on rocuronium-induced block in the Rhesus monkey, using a simple model of equilibration of complex formation.
de Boer HD; van Egmond J; van de Pol F; Bom A; Driessen JJ; Booij LH
Br J Anaesth; 2006 Nov; 97(5):681-6. PubMed ID: 17018564
[TBL] [Abstract][Full Text] [Related]
9. Reversibility of rocuronium-induced profound neuromuscular block with sugammadex in younger and older patients.
Suzuki T; Kitajima O; Ueda K; Kondo Y; Kato J; Ogawa S
Br J Anaesth; 2011 Jun; 106(6):823-6. PubMed ID: 21531745
[TBL] [Abstract][Full Text] [Related]
10. The effect of residual neuromuscular blockade on the speed of reversal with sugammadex.
White PF; Tufanogullari B; Sacan O; Pavlin EG; Viegas OJ; Minkowitz HS; Hudson ME
Anesth Analg; 2009 Mar; 108(3):846-51. PubMed ID: 19224792
[TBL] [Abstract][Full Text] [Related]
11. Reversal of rocuronium-induced profound neuromuscular block by sugammadex in Duchenne muscular dystrophy.
de Boer HD; van Esmond J; Booij LH; Driessen JJ
Paediatr Anaesth; 2009 Dec; 19(12):1226-8. PubMed ID: 19863737
[TBL] [Abstract][Full Text] [Related]
12. Sugammadex given for rocuronium-induced neuromuscular blockade in infants: a retrospectıve study.
Ozmete O; Bali C; Cok OY; Turk HE; Ozyilkan NB; Civi S; Aribogan A
J Clin Anesth; 2016 Dec; 35():497-501. PubMed ID: 27871583
[TBL] [Abstract][Full Text] [Related]
13. Reversal of rocuronium-induced (1.2 mg kg-1) profound neuromuscular block by accidental high dose of sugammadex (40 mg kg-1).
Molina AL; de Boer HD; Klimek M; Heeringa M; Klein J
Br J Anaesth; 2007 May; 98(5):624-7. PubMed ID: 17347184
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of sugammadex for the reversal of moderate and deep rocuronium-induced neuromuscular block in patients pretreated with intravenous magnesium: a randomized controlled trial.
Czarnetzki C; Tassonyi E; Lysakowski C; Elia N; Tramèr MR
Anesthesiology; 2014 Jul; 121(1):59-67. PubMed ID: 24608361
[TBL] [Abstract][Full Text] [Related]
15. Effects of sugammadex on incidence of postoperative residual neuromuscular blockade: a randomized, controlled study.
Brueckmann B; Sasaki N; Grobara P; Li MK; Woo T; de Bie J; Maktabi M; Lee J; Kwo J; Pino R; Sabouri AS; McGovern F; Staehr-Rye AK; Eikermann M
Br J Anaesth; 2015 Nov; 115(5):743-51. PubMed ID: 25935840
[TBL] [Abstract][Full Text] [Related]
16. Sugammadex, a new reversal agent for neuromuscular block induced by rocuronium in the anaesthetized Rhesus monkey.
de Boer HD; van Egmond J; van de Pol F; Bom A; Booij LH
Br J Anaesth; 2006 Apr; 96(4):473-9. PubMed ID: 16464982
[TBL] [Abstract][Full Text] [Related]
17. Reversal of profound rocuronium-induced blockade with sugammadex: a randomized comparison with neostigmine.
Jones RK; Caldwell JE; Brull SJ; Soto RG
Anesthesiology; 2008 Nov; 109(5):816-24. PubMed ID: 18946293
[TBL] [Abstract][Full Text] [Related]
18. Effective reversal of moderate rocuronium- or vecuronium-induced neuromuscular block with sugammadex, a selective relaxant binding agent.
Suy K; Morias K; Cammu G; Hans P; van Duijnhoven WG; Heeringa M; Demeyer I
Anesthesiology; 2007 Feb; 106(2):283-8. PubMed ID: 17264722
[TBL] [Abstract][Full Text] [Related]
19. Reversal of rocuronium-induced neuromuscular block by the selective relaxant binding agent sugammadex: a dose-finding and safety study.
Sorgenfrei IF; Norrild K; Larsen PB; Stensballe J; Ostergaard D; Prins ME; Viby-Mogensen J
Anesthesiology; 2006 Apr; 104(4):667-74. PubMed ID: 16571960
[TBL] [Abstract][Full Text] [Related]
20. Reversal of rocuronium-induced (1.2 mg/kg) profound neuromuscular block by sugammadex: a multicenter, dose-finding and safety study.
de Boer HD; Driessen JJ; Marcus MA; Kerkkamp H; Heeringa M; Klimek M
Anesthesiology; 2007 Aug; 107(2):239-44. PubMed ID: 17667567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
